Andrew Wayland - Director of Business Development

Master of Business Administration MBA 

Clinical Research and Healthcare Administrator, Advance innovative discoveries for the treatment of human disease.

Life Science professional and strategist with over 15 years of experience building disruptive partnerships across academia, CROs, diagnostics, biotechnology, pharmaceutical and medical device organizations.

Andrew's professional goal is to successfully impact healthcare organizations to advance innovative therapeutic discoveries for the treatment of human disease.

Highly recognized for accomplishments with Clinical Research Operations, Project Management, Business Development and Sponsored Research Funding within Healthcare Clinical Research. These results maximize efficiencies and accelerate cost-effective drug, medical device and therapeutic development.

Sponsored research funding derived from Federal (NIH, DoD, NSF), State (CPRIT), Foundation/Philanthropic, and Biopharma/Pharmaceutical research funding proposals (RFPs)

Therapeutic Areas: Oncology (Hematology and Solid Tumor), Immunology, Neurology/CNS, Clinical Pharmacology, Digital Health (AI), Medical Device, Therapeutic Diagnostics, Healthcare Prevention, Educational Services and Other Indications

Specialties: Clinical Operations, Business Development, Research Proposal Management, Clinical Trial Management, Business Entrepreneurship, ICH/GCP guidelines, GLP/GMP regulations, Research Analytics, People Leadership and Human Resource Management.